The best studied oncogenic activities of E6 and E7 are E7’s inactivation of the retinoblastoma tumor suppressor (pRB), which leads to elevated E2F activity and unscheduled cellular DNA synthesis, and E6’s inactivation the p53 tumor suppressor [21–23]. This evidence concerns the gene TP53 and neoplasm.